Skip to main content
Clinical Trials/NCT00835055
NCT00835055
Withdrawn
N/A

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

St. Claraspital AG1 site in 1 countryApril 2005
ConditionsRectal Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rectal Cancer
Sponsor
St. Claraspital AG
Locations
1
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Registry
clinicaltrials.gov
Start Date
April 2005
End Date
April 1, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Beatrice Kern

Dr.med

St. Claraspital AG

Eligibility Criteria

Inclusion Criteria

  • locally advanced rectal cancer uT3 or uT4
  • no distant metastasis
  • neoadjuvant radiochemotherapy required

Exclusion Criteria

  • rejection of radiochemotherapy

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials